Explore Advanced Diagnostics
Discover our molecular oncology assays designed to identify rare tumor cells and cell free tumor DNA for targeted therapy.
Molecular Oncology
Advanced assays for precision cancer care.
Rare Tumor Detection
Identify rare tumor cells with high sensitivity.
Cell-Free DNA
Monitor cell-free tumor DNA effectively.
Our Process
This section outlines our molecular oncology workflow, helping clinicians understand how to initiate testing and utilize advanced diagnostics effectively.
Step One: Sample Collection
This is the initial phase where patient samples are securely gathered and prepared for advanced molecular oncology testing and comprehensive genomic profiling.
Step Two: Assay Analysis
This stage details our laboratory procedures as we analyze cell-free tumor DNA and identify rare tumor cells with high precision.
Targeted Therapy Insights
This final report delivers actionable diagnostic data, empowering medical teams to select precise therapies and monitor treatment progress accurately.
Clinical Insights and Patient Success Stories
This section outlines our diagnostic process, guiding clinicians through sample submission, advanced molecular profiling, and comprehensive result delivery.
Advancing Targeted Therapy for Rare Cancers
This case study highlights how our molecular oncology assays identified rare tumor cells, enabling clinicians to tailor effective targeted therapies for their patients.
Monitoring Treatment Response with Precision
This case study explores how tracking cell-free tumor DNA helped medical teams evaluate therapy efficacy in real-time and adapt treatment strategies.
Elevating Oncology Diagnostics with Advanced Assays
This case study showcases how our clinical laboratory streamlined genomic profiling workflows, reduced turnaround times, and improved patient outcomes.
Discover Advanced Molecular Oncology Diagnostics Today
This section encourages clinicians and patients to learn more about our assays. It highlights the benefits of identifying rare tumor cells and cell-free DNA for targeted cancer therapy.
